Koninklijke Philips Total Current Liabilities 2010-2024 | PHG

Koninklijke Philips total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Koninklijke Philips total current liabilities for the quarter ending June 30, 2024 were $9.435B, a 10.73% decline year-over-year.
  • Koninklijke Philips total current liabilities for 2023 were $8.969B, a 7.29% increase from 2022.
  • Koninklijke Philips total current liabilities for 2022 were $8.359B, a 5.16% decline from 2021.
  • Koninklijke Philips total current liabilities for 2021 were $8.814B, a 0.24% decline from 2020.
Koninklijke Philips Annual Total Current Liabilities
(Millions of US $)
2023 $8,969
2022 $8,359
2021 $8,814
2020 $8,836
2019 $7,815
2018 $9,381
2017 $7,761
2016 $11,589
2015 $11,180
2014 $12,265
2013 $11,259
2012 $12,803
2011 $13,013
2010 $14,287
2009 $11,227
Koninklijke Philips Quarterly Total Current Liabilities
(Millions of US $)
2024-06-30 $9,435
2023-06-30 $8,801
2023-03-31
2022-06-30 $8,971
2021-06-30 $10,568
2020-06-30 $8,248
2019-06-30 $8,013
2018-06-30 $8,495
2017-06-30 $11,424
2016-12-31 $11,589
2016-09-30 $10,230
2016-06-30 $10,019
2016-03-31 $10,859
2015-12-31 $11,180
2015-09-30 $10,753
2015-06-30 $11,051
2015-03-31 $12,003
2014-12-31 $12,265
2014-09-30 $12,485
2014-06-30 $11,302
2014-03-31 $11,244
2013-12-31 $11,259
2013-09-30 $12,096
2013-06-30 $12,296
2013-03-31 $12,988
2012-12-31 $12,803
2012-09-30 $11,399
2012-06-30 $11,464
2012-03-31 $12,347
2011-12-31 $13,013
2011-09-30 $11,833
2011-06-30 $11,458
2011-03-31 $13,316
2010-12-31 $14,287
2010-09-30 $12,817
2010-06-30 $13,827
2010-03-31 $12,876
2009-12-31 $11,227
2009-09-30 $12,414
2009-06-30 $10,873
2009-03-31 $11,508
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $29.016B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $199.879B 25.82
Stryker (SYK) United States $137.705B 32.18
Boston Scientific (BSX) United States $121.595B 37.03
Medtronic (MDT) Ireland $113.026B 16.82
EssilorLuxottica (ESLOY) France $104.378B 0.00
Haleon (HLN) United Kingdom $48.118B 35.17
Lonza Group Ag (LZAGY) Switzerland $45.437B 0.00
ResMed (RMD) United States $34.974B 30.79
Terumo (TRUMY) Japan $27.876B 39.37
Zimmer Biomet Holdings (ZBH) United States $21.644B 13.63
Baxter (BAX) United States $20.086B 13.62
Insulet (PODD) United States $16.555B 69.65
Smith & Nephew SNATS (SNN) United Kingdom $13.426B 0.00
Bio-Rad Laboratories (BIO) United States $9.489B 31.44
Demant (WILYY) Denmark $9.197B 0.00
BellRing Brands (BRBR) United States $7.672B 32.44
Lantheus Holdings (LNTH) United States $7.508B 18.02
ICU Medical (ICUI) United States $4.304B 41.08
TG Therapeutics (TGTX) United States $3.909B 41.39
Haemonetics (HAE) United States $3.870B 19.14
Perrigo (PRGO) Ireland $3.841B 12.14
GN Store Nord (GNNDY) Denmark $3.758B 22.64
Neogen (NEOG) United States $3.736B 39.18
Prestige Consumer Healthcare (PBH) United States $3.644B 18.16
Envista Holdings (NVST) United States $3.298B 17.60
QuidelOrtho (QDEL) United States $3.108B 19.59
Agios Pharmaceuticals (AGIO) United States $2.591B 0.00
Maravai LifeSciences Holdings (MRVI) United States $2.311B 0.00
Green Thumb Industries (GTBIF) United States $2.171B 36.43
LeMaitre Vascular (LMAT) United States $1.996B 53.20
AdaptHealth (AHCO) United States $1.524B 11.00
InMode (INMD) Israel $1.466B 9.34
Warby Parker (WRBY) United States $1.466B 0.00
AtriCure (ATRC) United States $1.363B 0.00
Owens & Minor (OMI) United States $1.219B 9.41
Verano Holdings (VRNOF) United States $1.114B 0.00
BioLife Solutions (BLFS) United States $1.094B 0.00
Evolus (EOLS) United States $1.023B 0.00
PetIQ (PETQ) United States $0.920B 23.32
Phibro Animal Health (PAHC) United States $0.897B 18.61
National Vision Holdings (EYE) United States $0.864B 27.48
Cresco Labs (CRLBF) United States $0.801B 0.00
Surmodics (SRDX) United States $0.561B 119.09
Quanterix (QTRX) United States $0.543B 0.00
ZimVie (ZIMV) United States $0.454B 42.23
VAREX IMAGING (VREX) United States $0.451B 13.62
Valneva SE (VALN) France $0.422B 0.00
Canopy Growth (CGC) Canada $0.406B 0.00
Jin Medical (ZJYL) China $0.397B 0.00
TerrAscend (TSNDF) Canada $0.333B 0.00
Cerus (CERS) United States $0.330B 0.00
OraSure Technologies (OSUR) United States $0.321B 8.29
Aurora Cannabis (ACB) Canada $0.320B 0.00
Biote (BTMD) United States $0.319B 14.70
Viemed Healthcare (VMD) United States $0.287B 30.79
Sanara MedTech (SMTI) United States $0.272B 0.00
Zynex (ZYXI) United States $0.260B 45.44
Utah Medical Products (UTMD) United States $0.234B 15.52
Ayr Wellness (AYRWF) United States $0.232B 0.00
Omeros (OMER) United States $0.228B 0.00
MacroGenics (MGNX) United States $0.207B 0.00
Organigram Holdings (OGI) Canada $0.196B 0.00
High Tide (HITI) Canada $0.170B 70.33
Capricor Therapeutics (CAPR) United States $0.167B 0.00
FitLife Brands (FTLF) United States $0.153B 20.62
Brainsway (BWAY) Israel $0.140B 168.00
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Rockwell Medical (RMTI) United States $0.125B 0.00
Quipt Home Medical (QIPT) United States $0.124B 0.00
Veru (VERU) United States $0.113B 0.00
Fonar (FONR) United States $0.110B 11.15
Jushi Holdings (JUSHF) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.099B 24.20
InterCure (INCR) Israel $0.085B 14.31
Safety Shot (SHOT) United States $0.082B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
Zevia PBC (ZVIA) United States $0.076B 0.00
Cellectar Biosciences (CLRB) United States $0.075B 0.00
Modular Medical (MODD) United States $0.073B 0.00
MariMed (MRMD) United States $0.065B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.056B 3.63
Exagen (XGN) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.041B 0.00
Apyx Medical (APYX) United States $0.036B 0.00
Bright Green (BGXX) United States $0.028B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.026B 0.00
Nephros (NEPH) United States $0.019B 0.00
GlucoTrack (GCTK) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Agape ATP (ATPC) $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
United-Guardian (UG) United States $0.000B 20.47
SNDL (SNDL) Canada $0.000B 0.00